These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 27662011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
    Pizzi M, Gergis U, Chaviano F, Orazi A.
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
    [Abstract] [Full Text] [Related]

  • 4. Enlarged spleen is associated with low neutrophil and platelet engraftment rates and poor survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Shimomura Y, Hara M, Katoh D, Hashimoto H, Ishikawa T.
    Ann Hematol; 2018 Jun; 97(6):1049-1056. PubMed ID: 29455235
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation.
    Alchalby H, Zabelina T, Stübig T, van Biezen A, Bornhäuser M, Di Bartolomeo P, Beelen D, Cahn JY, Dreger P, Schroyens W, de Witte T, Olavarria E, Kröger N, Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):279-81. PubMed ID: 24201159
    [Abstract] [Full Text] [Related]

  • 6. [Successful management of splenomegaly with ruxolitinib prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia transformed from post-polycythemia vera myelofibrosis].
    Fujishima M, Fujishima N, Kitadate A, Guo Y, Watanabe A, Ubukawa K, Nara M, Yoshioka T, Kameoka Y, Takahashi N.
    Rinsho Ketsueki; 2017 Feb; 58(7):743-748. PubMed ID: 28781268
    [Abstract] [Full Text] [Related]

  • 7. Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis.
    Alchalby H, Yunus DR, Zabelina T, Ayuk F, Kröger N.
    Bone Marrow Transplant; 2016 Sep; 51(9):1223-7. PubMed ID: 27088376
    [Abstract] [Full Text] [Related]

  • 8. Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.
    Kröger N, Thiele J, Zander A, Schwerdtfeger R, Kobbe G, Bornhäuser M, Bethge W, Schubert J, de Witte T, Kvasnicka HM, MDS-Subcommittee of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation.
    Exp Hematol; 2007 Nov; 35(11):1719-22. PubMed ID: 17976523
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.
    Gergis U, Kuriakose E, Shore T, Mayer S, Mark T, Pearse R, Schuster M, Feldman E, Roboz G, Ritchie E, Scandura J, Wang H, Zhou XK, Silver RT, van Besien K.
    Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):297-303. PubMed ID: 27025789
    [Abstract] [Full Text] [Related]

  • 11. Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT.
    Polverelli N, Hernández-Boluda JC, Czerw T, Barbui T, D'Adda M, Deeg HJ, Ditschkowski M, Harrison C, Kröger NM, Mesa R, Passamonti F, Palandri F, Pemmaraju N, Popat U, Rondelli D, Vannucchi AM, Verstovsek S, Robin M, Colecchia A, Grazioli L, Damiani E, Russo D, Brady J, Patch D, Blamek S, Damaj GL, Hayden P, McLornan DP, Yakoub-Agha I.
    Lancet Haematol; 2023 Jan; 10(1):e59-e70. PubMed ID: 36493799
    [Abstract] [Full Text] [Related]

  • 12. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
    Ciurea SO, Sadegi B, Wilbur A, Alagiozian-Angelova V, Gaitonde S, Dobogai LC, Akard LP, Hoffman R, Rondelli D.
    Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
    Barosi G, Bacigalupo A.
    Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
    [Abstract] [Full Text] [Related]

  • 15. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J, Kvasnicka HM, Beelen DW, Flucke U, Spoer C, Paperno S, Leder LD, Schaefer UW.
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [Abstract] [Full Text] [Related]

  • 16. Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia.
    Scott BL, Storer BE, Greene JE, Hackman RC, Appelbaum FR, Deeg HJ.
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):345-54. PubMed ID: 17317588
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN, Labopin M, Blaise D, Niederwieser D, Ciceri F, Ganser A, Arnold R, Afanasyev B, Vigouroux S, Milpied N, Hallek M, Cornelissen JJ, Schwerdtfeger R, Polge E, Baron F, Esteve J, Gorin NC, Schmid C, Giebel S, Mohty M, Nagler A.
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [Abstract] [Full Text] [Related]

  • 19. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK, Kim DW, Lee JW, Min WS, Kim CC.
    Acta Haematol; 2000 Feb; 104(4):185-92. PubMed ID: 11279309
    [Abstract] [Full Text] [Related]

  • 20. Transplantation of autologous peripheral blood stem cells mobilized using GM-CSF for acute leukemia with myelofibrosis.
    Mehta J, Powles RL, Shepherd V, Dainton M, Treleaven J.
    Leuk Lymphoma; 1993 Sep; 11(1-2):157-8. PubMed ID: 8106067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.